Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.082 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |